POPULARITY
5 episodes with cordis
8 episodes with cordis
2 episodes with cordis
2 episodes with cordis
2 episodes with cordis
2 episodes with cordis
4 episodes with cordis
2 episodes with cordis
3 episodes with cordis
Lincoln and Billy are in Cordis. Lincoln is about to meet with Juanita. Billy is sneaking in another round of training with Morgan Stone, former assistant to Kellius Droman, father of Delilah. After Lincoln's meeting, he intends to take Billy shopping at the Clearinghaüs to see if they can find Billy a signature weapon, something Billy can train with and master. Lincoln sent a message to Peanut, manager of the Clearinghaüs, asking to set some ideal weapons aside for the purpose. Did Peanut find something ideally suited to Billy's skills? Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2025 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Peanut drives a hard bargain, but think of what she could do online, with a new 3-year .com domain, all while saving ninety-nine percent on the first year by using GoDaddy Promo Code CJCFOSSIG3! Learn more about your ad choices. Visit megaphone.fm/adchoices
Dante Oganov is getting ready to make another run at Callista to take over her criminal holdings in Lumencia. Dante, with help from Lincoln's friend and former lawyer Dillon Cantrell, set up a bounty to test Lincoln. Lincoln had to defeat a swarm of lagrounes, water-based undead that attacked from beneath the Bendelson Bridge near downtown. Dante is on the run from Vestinian, who once tasked Dante to find Billy Middleton. Dante failed. Vestinian wants payback. He hired famed bounty hunter Icepick to find Dante. Icepick, and his familiar Herbie, a giant, diamond-plated tortoise known as a diamortuga, had an early run-in with Lincoln and Billy at the bridge just before Lincoln & co took out the lagrounes. Now, Lincoln has been summoned to Cordis for a talk with Juanita Socorro, the Clostator of the Bastion. Lincoln does not know what she wants, but he has no choice but to obey her summons. Billy is joining Lincoln on the trip. Together, they will visit the Clearinghaüs pawnshop and find Billy's signature weapon. Lincoln, of course, is unaware that Billy has been sneaking off to Cordis for magical training sessions with Morgan Stone, the former assistant of Kellius Droman and former protector of Droman's daughter, Delilah. Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2025 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Something fishy about that lagroune contract, sure, but there ain't nothing fishy about our GoDaddy Promo Code CJCFOSSIG3! Save 99% on the first year of a new dot-com domain registration. Learn more about your ad choices. Visit megaphone.fm/adchoices
Magda successfully operated the Cursed Armor of Sir Arnault the Pure. Will the armor provide a cheat to her agoraphobia? While possessing the armor, can she leave the Old Stone Church for the first time in years? Lincoln's brother Lukas and sister Sophia showed up unannounced at the Old Stone Church and delivered a message — the Clostator, the leader of the Bastion, demands Linc's presence in Cordis. To the Franks siblings, the Clostator is also known as “Aunty Juanita,” as she was once the fighting partner of their father, Jacoby Franks, known as the greatest monster hunter of all time. Aunty Juanita doesn't do things like demand Lincoln's presence — so what is it she wants? Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2025 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. I hope I get to see Mags take a Dremel to the suit! If I were a DIY-er, I'd set up a spanking new dot-com domain and save 99% by using GoDaddy Promo Code CJCFOSSIG3! Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode of Broadway Drumming 101, we sit down with Andrew Beall, an accomplished percussionist, composer, and Broadway musician whose career spans international performances, musical theater orchestration, and a deep love for percussion. From his early days in Ohio to working on some of Broadway's biggest productions, Andrew shares insights into his journey, his influences, and his passion for composition.We dive into the art of orchestration, the challenges of subbing on Broadway, and how he balances multiple musical roles—including running Bachovich Music Publications and managing orchestras. Andrew also talks about adapting to technological advancements in music, the impact of Finale's discontinuation, and how biking in NYC keeps him in rhythm with the city's fast pace.Whether you're an aspiring Broadway musician or just love behind-the-scenes stories from the theater world, this episode is packed with wisdom, humor, and practical advice.Episode Highlights:
Billy's trip to Cordis goes south — and by “South,” we mean some violent stuff happens. Speaking of violence, Linc targets Ariella for payback. Meanwhile, Lukas is being radicalized by Basil. Can Sofia do anything to stop it? Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2025 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Billy's got a rodent problem. He should use CJCFOSSIG3, which is our GoDaddy Promo Code, to get himself a three-year dot-com domain registration for ninety-nine percent off … and find an exterminator. Learn more about your ad choices. Visit megaphone.fm/adchoices
Entrepreneur Duke Rohlen creates California-based Ajax Health under a new model. Partnering with private equity firms, Rohlen considers a $1 billion bid to buy medical device maker Cordis. If Ajax's bid is successful, they will invest an additional $300 million to fund an accelerator to develop innovative new products to drive growth. Is Cordis the right opportunity for Rohlen and his team? Ajax Health founder Duke Rohlen (HBS MBA 2001) and HBS Professor Regina Herzlinger join host Brian Kenny to discuss the key success factors for both start-up and established medical technology firms. The case “Ajax Health: A New Model for Medical Technology Innovation” showcases how to structure a firm—in any industry—to maximize innovation and financial returns by better aligning incentives for the different skill sets required.
In this episode of BioTalk, host Rich Bendis welcomes Ric Hughen, CEO of Linshom Medical, and Talia Feldman, Software Engineer at Linshom Medical, to discuss their groundbreaking advancements in respiratory monitoring technology. As the main winners of the 2024 Crab Trap Competition at the 10th Annual BioHealth Capital Region Week, Ric and Talia share Linshom's mission to improve patient safety through their innovative and accessible respiratory monitoring devices. Ric explains how Linshom is addressing critical gaps in respiratory monitoring by bringing operating-room-quality data to patient bedsides and homes. Talia shares insights from the engineering side, highlighting the challenges and breakthroughs in developing reliable and user-friendly technology. The conversation explores Linshom's roots in the BioHealth Capital Region and how its partnerships and resources have been instrumental to the company's growth. Talia reflects on her experience presenting at the Crab Trap Competition, and Ric discusses how this recognition aligns with Linshom's broader visibility and growth objectives. Looking ahead, Ric and Talia provide a glimpse into Linshom's future, including upcoming milestones and advancements that promise to further revolutionize respiratory care. Don't miss this episode filled with innovation, collaboration, and a vision for transforming patient safety. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Richard Hughen's thirty years of medical device experience spans three Fortune 500 and three start-up companies with two successful exits to date. He is currently CEO of Linshom Medical, a start-up that is first to deliver operating room quality respiratory data to the patient bedside and home. Ric was an investor and member of the executive team that built start-up CSA Medical, from a technology license (U.S. Navy) through product development, animal trials, clinical trials, five FDA clearances, CE mark, three rounds of funding ($50M), commercial growth and a 2019 sale to Steris. Ric was Managing Director of LearnWare, a life science focused e-learning start-up, which was successfully built and sold to a private equity fund. He is currently a reviewer for the National Science Foundation's SBIR/STTR program, an Entrepreneur in Residence for Johns Hopkins Tech Ventures, an advisory board member of George Mason University's Bioengineering Alliance and a site miner for TEDCO at the University of Maryland Medical Center in Baltimore. Earlier in his career, Ric led various senior management, marketing, training and sales teams for Johnson & Johnson, BD, Abbott and Cordis. Ric holds MBA and BS degrees from The Pennsylvania State University. Talia Feldman is a software engineer at Linshom Medical, an innovative healthcare technology company at the forefront of transforming respiratory monitoring. Talia received a B.S. in Computer Science with a concentration in Artificial Intelligence from the University of Delaware. Upon graduation she worked as a software engineer in the Maritime Division at Leidos. Now combining her technical skills with a passion for innovation, Talia supports Linshom Medical's development of providing continuous predictive respiratory monitoring to improve patient care.
Damon gets to talk to Andrew about The Percussion People, Drum Corps, Cordis, composing, contracting, orchestrating, Ohio, Jeopardy and much more! There's also other segments!
Working together, Lincoln, Billy, Magda, and Ariella learned that Teddy's lair is beneath a Big Nasty's restaurant in Cordis, close to the supernatural pawnshop known as “the Clearinghaus,” and also close to the Bastion's fortress headquarters. The Bastion has a magical interference zone around it, a zone that includes the Clearinghaus and Big Nasty's. This zone, affected by a persistent spell known as “mesh-buzz,” hides the detection of all meshwork within it. It also makes magic unpredictable — sometimes magic works fine, sometimes it produces unexpected results, and sometimes it doesn't work at all. Lincoln and Billy left for the Clearinghaus, where they planned to meet with rixators Sophia Franks and Lukas Franks, Lincoln's sister and brother, respectively, and with Kellius Droman and his assistant Morgan Stone. SLAY Episode 68 is free courtesy of our GoDaddy Promo Codes. The coupon code CJCFOSSIG3 saves 99% off the first year of a three-year domain. Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2024 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Learn more about your ad choices. Visit megaphone.fm/adchoices
Medsider Radio: Learn from Medical Device and Medtech Thought Leaders
In this episode of Medsider Radio, we had a fun chat with Trent Reutiman, CEO of Mercator MedSystems. Trent and his team have developed microinfusion devices with the unique ability to locally and directly deliver targeted therapeutics during catheter-based interventions where mechanical therapy isn't sufficient. Trent has 25 years of leadership experience in medtech including roles in sales, marketing, and business management with a focus on minimally invasive interventional products for companies like IDEV, ROX Medical, RITA Medical Systems, Guidant, and Cordis.In this interview, Trent talks about the importance of generating data, how to balance commercial efforts with clinical initiatives, and why meticulous management is critical for successful commercialization. Before we dive into the discussion, I wanted to mention a few things:First, if you're into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You'll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume V. If you're interested, go to medsider.com/subscribe to learn more.Lastly, if you'd rather read than listen, here's a link to the full interview with Trent Reutiman.
Teddy Two-Fingers missed his shot at kidnapping Delilah Droman, who he wanted as his “foreman” in his malevolent nightmare-harvesting operation. Can he find a replacement candidate? Delilah's father, Kellius Droman, hired Lincoln as Delilah's bodyguard. When Kellius hunts Teddy Two-Fingers or trains Billy, Lincoln must stay at the Droman Mansion and protect young Delilah. Surprisingly, Lincoln and Delilah have hit it off. She trusts he can keep her safe, while he benefits from her optimism and youthful energy that he can't experience from his own child, Sam, who remains trapped on The Shelf — where Teddy put him. Billy's training with Kellius goes on at Kellius's facility, the “Nonagon,” in the mystical city of Cordis. Billy needs to find his “loom,” the structure upon which he can channel the powerful, innate magic that courses through his body. Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2024 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Learn more about your ad choices. Visit megaphone.fm/adchoices
In this episode, we will learn from Andrea Cordis, MS, OTA (she/her/hers). Andrea has been a COTA since 2004. She has practiced in a variety of settings including skilled nursing, home health, inpatient psych, community-based mental health, and inpatient rehab. Andrea also worked as a lab instructor and fieldwork assistant in a masters of OT program. In addition to her OT education, Andrea also holds a BS in health science and an MS in higher education administration. She recently made the move to Massachusetts Councils on Aging as the training and education manager, using her OT skills in an uncommon way! Andrea is also a trauma-informed yoga instructor. When she is not working at MCOA, teaching yoga or working per diem in inpatient rehab, you can find her baking, hiking, or traveling!Contact & Resources:Here is a link to Conversations with an OT podcast: https://open.spotify.com/show/3QtawOTioXdwC0Ofk1OyS0?si=83444bdca79148f7MCOA Website - Massachusetts Council on AgingNCOA Website - National Councils on AgingI am also on LinkedIn: https://www.linkedin.com/in/andrea-cordis-7391b528a/As always, I welcome any feedback & ideas from all of you or if you are interested in being a guest on future episodes, please do not hesitate to contact Patricia Motus at transitionsot@gmail.com or DM via Instagram @transitionsot THANK YOU for LISTENING, FOLLOWING, DOWNLOADING, RATING, REVIEWING & SHARING “The Uncommon OT Series” Podcast with all your OTP friends and colleagues! Full Episodes and Q & A only available at: https://www.wholistic-transitions.com/the-uncommon-ot-series Sign Up NOW for the Transitions OT Email List to Receive the FREE Updated List of Uncommon OT Practice Settings https://www.wholistic-transitions.com/transitionsot For Non-Traditional OT Practice Mentorship w/ Patricia: https://docs.google.com/forms/d/e/1FAIpQLSeC3vI5OnK3mLrCXACEex-5ReO8uUVPo1EUXIi8FKO-FCfoEg/viewform BIG THANKS to our sponsors Picmonic & Truelearn USE DISCOUNT CODE “TransitionsOT” to Score 20% OFF Your Membership Today! Happy Listening Friends! Big OT Love! All views are mine and guests own.
For Cordis Webb, helping people is his passion. He recruited people into the healthcare industry, but really found his home in the real estate industry in Sacramento. Matt shares how managing a poker room helped him in mortgage. With all the challenges that buyers and sellers are facing these days, the answer is sometimes starting with the questions. The ability to listen is critical and Cordis has kept his ears open. Together, he and Matt dive into helping buyers and sellers find the right homes at the right prices. Dive into the current state of all things real estate - Welcome back to the Get Better Everyday Podcast! Want to help the show? Sharing this episode with a friend or on social media is the number 1 way to help us grow. Leaving 5-star reviews on Spotify and Apple Podcasts are also great ways to give back. Visit mattgouge.com to learn more! --- Send in a voice message: https://podcasters.spotify.com/pod/show/matt-gouge/message
Serial kidnapper Teddy Two-Fingers tried to abduct thirteen-year-old Delilah Droman from the mansion where she lives with her father, the billionaire wizard Kellius Droman. Lincoln foiled that attempt, driving off Teddy and two members of his gang: Hiamana, a mage, and Sophie, a brawler with long, dangerous claws. In the battle, Lincoln cut off Sophie's left arm below the elbow. Afterward, Kellius Droman agreed to train Billy in the ways of magic in exchange for Lincoln serving as Delilah's bodyguard when Kellius was away from home. Now, Billy is in Cordis at Kellius's “Nonagon,” ready for his first training session, while Lincoln returns to the Droman Mansion for his first shift protecting Delilah. Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2024 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Learn more about your ad choices. Visit megaphone.fm/adchoices
To cover the mortgage, Lincoln has to hit up a pawnshop in Cordis. While he's in that magical city, he returns to the Bastion for the first time since he quit his life as a rixator. Created by Scott Sigler and Rob Otto Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2024 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Learn more about your ad choices. Visit megaphone.fm/adchoices
Coalition negotiations are 'scooting' along. That was the message from the leaders of National and New Zealand First, as speed-date-style talks to form the government reached their 13th day in Auckland. Yesterday's venue was the Pullman Hotel. Today it was a second former managed isolation hotel, the Cordis. Christopher Luxon and Winston Peters met first earlier this afternoon and ACT leader David Seymour is due to arrive for a separate discussion shortly. All this after National's Campaign Manager Chris Bishop arrived late, dishevelled, splattered in spilt coffee and on a lime scooter. Our political reporter Katie Scotcher on the wild ride of coalition talks.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, November 8, 2023. Check out the show notes for links to the stories we discuss today at MassDevice.com/podcast. Enable Injections this week announced it added a finance veteran to its board of directors. Fast Five hosts Danielle Kirsh and Sean Whooley discuss the new addition and the optimism they bring to the table. Onward's spinal cord stimulation demonstrated improved mobility in patients with Parkinson's disease, according to a new study. Whooley shares the key points of the study and the reaction of participants that were in the study. Cordis announced its new CEO. Find out who is taking over the corner office. Philips received significant funding from the Gates Foundation for AI-powered maternal health ultrasounds. Hear how the funding will support underserved communities. Johnson & Johnson gave an update on its Ottava surgical robot. Whooley details the company's plans for the robot and some of the features on it.
A college introduction to biomechanics set Nitin Salunke on an expected path into the medical device industry. But once his course was set Salunke helped manage innovative product launches at several large medical device companies including WL Gore, Cordis and Covidien/Medtronic. But Salunke always had his eyes on leading a start-up. In this discussion you'll learn how he used each opportunity to help achieve that dream. Today, he leads Supira Medical, a white-hot startup developing a new type of pVAD. Salunke will also be a speaker at the upcoming DeviceTalks West meeting. Thanks for listening to this episode of DeviceTalks Weekly. Subscribe to the DeviceTalks Podcast Network on any major podcast channel.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here's what you need to know for today, October 3, 2023. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. The FDA this week approved Enable Injections' wearable injector. Fast Five hosts Sean Whooley and Danielle Kirsh share what the wearable injector does and what executives are saying about the approval. Boston Scientific announced the launch of its next-generation insertable cardiac monitor. Find out what this next-gen system does, who some of the key players in the ICM space are and more in today's episode. Pulse Biosciences and CardioNXT are partnering up to initiate a pulsed-field ablation trial. Whooley details what the goal of the collaboration is and how the two companies plan to achieve it. SmileDirectClub has filed for Chapter 11 bankruptcy protection and announced plans to recapitalize. Hear more about the announcement and what the recapitalization process will entail. Cordis has acquired drug-eluting balloon maker MedAlliance for up to $1.135 billion. The Fast Five hosts discuss the financial details of the deal and some of the comments that executives had about the deal.
What are the 17 United Nations Sustainable Development Goals? What are the biggest challenges in pursuing and achieving those goals? How does technology play a role? And what's the best way for government, academia, and industry to cooperate and collaborate in support of fundamental research? We will learn those answers and more in this episode with Declan Kirrane, the Chairman of the Science Summit at the United Nations General Assembly, and founder and managing director of ISC Intelligence in Science. Declan has more than 25 years of experience as a global senior advisor to governments and industry on science research, science policy and related regulation. He has been actively promoting a more significant role for science within the context of the United Nations General Assembly since 2010. This has culminated in the annual Science Summit within the context of the UN's General Assembly. The focus of the Summit is on the role and contribution of science to attain the United Nations Sustainable Development Goals – or SDGs. The current edition – UNGA78 - takes place from September 12-29, and will bring together thought leaders, scientists, technologists, policymakers, philanthropists, journalists, and community leaders to increase health science and citizen collaborations to promote the importance of supporting science. And we are thrilled that Oracle will be part of the Science Summit with a few of our executives speaking and attending, including Alison Derbenwick Miller, global head and VP of Oracle for Research. -------------------------------------------------------- Episode Transcript: http://traffic.libsyn.com/researchinaction/Research_in_Action_S01_E19.mp3 00;00;00;00 - 00;00;22;29 What are the United Nations Sustainable Development Goals? What are the biggest challenges in pursuing and achieving those goals? And what's the best way for government, academia and industry to cooperate and collaborate in support of basic research? We'll get the answers to all this and more on Research in Action. 00;00;23;02 - 00;00;49;08 Hi, and welcome back to Research and Action, brought to you by Oracle for Research. I'm Mike Stiles and today's distinguished guest is Declan Kirrane, who is the chairman of the Science Summit at the United Nations General Assembly and the founder and managing director of ISC Intelligence and Science. And we're talking to a guy with more than 25 years of experience as a global senior advisor to governments and industry on science research, science policy and regulation around science. 00;00;49;10 - 00;01;17;07 Declan has been promoting a bigger role for science in the context of the U.N. General Assembly since 2010, and that's led to an annual science summit that focuses on the role and contribution of science to reach the United Nations Sustainable Development Goals or SDGs. The current edition UNGA 78 is happening September 12th through 29th and will bring together thought leaders, scientists, technologists, policymakers, philanthropists, journalists and community leaders. 00;01;17;09 - 00;01;37;02 We'll talk about increasing health science and citizen collaborations and why it's important to support science overall. Now, Oracle's actually going to be part of that science summit a few of the executives will be there speaking, including Alison Derbenwick Miller, who's global head and VP of Oracle for Research. Declan, thank you so much for being with us today. 00;01;37;08 - 00;01;58;13 Thanks, Michael. Great to be here. Thank you for the opportunity. Delighted to be here. What we want to hear all about the science summit at the U.N. General Assembly. But before we go there, tell me what got you not just into science, but science policies and your role in creating this summit? Well, first is, I suppose, the simple answer to that is happenstance. 00;01;58;13 - 00;02;21;10 I have to tell you, it was not planned. My primary degree is the history of art. And then I did law and probably needed a job after all of that. And then as a lot of people did in the late, late eighties, emigrated to the U.S. of A and on the basis that there was nothing going on in Ireland. 00;02;21;10 - 00;02;51;23 So opportunity beckoned and therefore from that worked on Wall Street and at a boutique mutual fund company. And then between one thing and another, I ended up in a in a boutique similar boutique company in Paris. And from that to Greece and from that, I got into more consulting side of things and from that started working for global multilateral bodies such as the World Bank and the IMF on a contract basis. 00;02;51;23 - 00;03;23;25 And then from that got more into telecoms and from that into into science coming out. And I suppose from the area of telecoms, infrastructure and data rather than, if you like, a bank scientist. And I suppose my history of art background gave me a wonderful perspective on policy, at least that's what I argue. And, and from that I got very interested and from the insights, but partly because the European Commission invited me and a couple of others to set up a dissemination service. 00;03;23;25 - 00;03;57;19 It's called Cordis. Cordis and the Cordis Information Service was designed by the European Commission to provide information on ongoing collaborative research and to provide information on publicly funded research opportunities in the course. The reason the European Union did that was to was to ensure that the information resulting from funding they're providing reached a very, very wide audience. So my job was to to do that and we built that out and that brought me into the area of science policy. 00;03;57;22 - 00;04;27;19 And I gradually began to understand the huge importance of science policy. And of course, 20 years ago science policy was not a thing, you know, it doesn't really exist in terms of policy making headlines, but it gradually came to be and as you know, it's it's part of the lexicon now. A lot of governments around the world have science policy priorities, and it's recognized as a driver for economic development and global competitiveness and driving solutions to global challenges. 00;04;27;19 - 00;04;51;05 So sciences is a thing, but 20 years ago it wasn't. So it's a relatively recent and I began quickly to appreciate the policy dimension of that, and that led me to work on policy that led me to understand policy mechanisms. And, you know, from my standpoint, I mean, there's no point in looking at some global challenges or many global challenges from a national perspective. 00;04;51;12 - 00;05;21;24 Really, it has to be global, it has to be international. That led me to engage with the United Nations. And from that, we just started to build from, as you say, from 2010, to start to build, engage with nations. And I really want to stress these were designed to be very, very simple to present not to a scientific forum, but to the U.N. for it to the mother ship, to the General Assembly, to diplomats, to policy and political leaders, and show them what science is. 00;05;21;24 - 00;05;43;04 And to give you a practical example, our first meeting was on biobanking. And you know, the main attention, wasn't it? What's biobanking? You see, that's exactly what we want. The want the question we wanted them to ask. And from Matt and that first mission, I think there's about 18 people in the room and we had about four or five diplomats last year at the Science summit. 00;05;43;06 - 00;06;07;02 We had approximately 60,000 participants. We had just under 400 sessions and we had 1600 speakers. So we've come a long way. And that really now is it's it's it's established. But we want to keep promoting. We want to keep science in the eye of the U.N. and we want to ensure that the future recognizes the contribution of science. 00;06;07;05 - 00;06;27;29 That's quite a journey. I think you did just about everything except science. Are you sure you weren't in the circus as well? Yeah, well, it's it's, you know, it's all true, you know, So, yeah, it's it's put a lot of it. Last 20 years has been on primarily on science. Yeah. Well in the intro I mentioned the United Nations Sustainable Development Goals or SDGs. 00;06;27;29 - 00;06;54;00 And our listeners are pretty savvy. They probably know about those, but I'm not savvy. So what are SDGs and how do they speak to global health and humanity in the in the in the mid nineties the the United Nations. And when I say the United Nations, I mean many of the United Nations constituent entities and agencies obviously were very concerned about what we generally call global challenges. 00;06;54;00 - 00;07;18;29 And in the area of health and other forms of well-being, the environment, climate, food security and safety and so on and so forth. And that led to a consensus that there needed to be, quote unquote, you know, how's this for a cliche? We have to do something. So that we have to do something resulted in the Millennium Development Goals, which were, as you can imagine, launched on the year 2000. 00;07;19;02 - 00;07;44;01 And they set forward these goals to to address challenges. And that that 50 years went by pretty quickly. And that then led on to a similar mechanism where you identify a challenge, you define a response to it, and then you allocate specific targets within that and get everyone to sign up to that and off you go now. 00;07;44;03 - 00;08;12;18 So that then that broad approach was repeated for the United Nations SDGs, the Sustainable Development Goals, of which there are 17. And they cover the headlines that you'd imagine between poverty reduction, hunger reduction, improved health, a life below water, life on land, addressing obviously biodiversity, climate and many other areas. And then we're in the middle of these now. 00;08;12;21 - 00;08;45;10 But already the world is turning its attention to the post SDG agenda. And this is where this probably where we are now. The United Nations is organizing the summit of the future September 2024, and that I suppose you could characterize that meeting rather I do as a a banging of heads together because there is a sense of crisis, there is a sense the SDGs are not being achieved, that progress towards the attainment of the SDGs is insufficient. 00;08;45;12 - 00;09;07;19 It is exclusive. It excludes many constituencies, many countries, and again, I won't enumerate them here, but I just present that as as the scenario. So there's now a lot of momentum behind what we know. What do we do next? Why old humble viewers? I don't think it's going to be a if you like, a goals oriented process. I think that's too simplistic. 00;09;07;19 - 00;09;41;01 The world. I think as we found out, is much, much more complex. And I think the issue of inclusion and equity are issues that are present in a way that they were not when the Millennium Development Goals and the Sustainable Development Goals were designed 30 and 50 years ago, respectively. And I think this equity dimension is going to give a far stronger voice to less developed nations. 00;09;41;01 - 00;10;07;05 And just on the back of an envelope calculation, I think if you take the OECD countries and change, you've probably got 30 nations that we could call a developed. And then I suppose the big questions that what about everybody else? And that is becoming a very stark consideration, which was not there. And this needs to be addressed in terms of inclusion and equity to a much, much greater extent than is currently the case. 00;10;07;05 - 00;10;37;01 And arguably then will lead to a more successful approach to whatever succeeds the SDGs, the SDGs. I'm interested in the mechanics behind that because I'm just kind of reading between the lines of what you're saying and it's like for this thing to have true accountability and for these goals to have any teeth at all. There does need to be a someone accountable, be a very good grasp of who the participants are going to be and some form of deadline. 00;10;37;04 - 00;11;01;19 Absolutely correct. Mike And that that was that the plan A the problem with that in in in in a word is it doesn't really work you've so many moving parts you've so many constituencies that it's you know, having this set table of goals and table of targets and allocating milestones know simply doesn't work. Now, why doesn't it work? 00;11;01;21 - 00;11;29;07 I believe in my view it is that many less developed nations don't have the wherewithal to achieve these SDGs. One needs investment, one needs skills, one needs training, one needs cooperation, one is finance. I mean, these are all requirements to make change it, particularly in the area of or particularly in every area. But if you look at health, if you look at energy transformation, if you look at digital transformation, they don't happen without moolah, without money. 00;11;29;14 - 00;11;48;22 So the question is, well, where's I coming from? The answer, I'm afraid, is it's not. And that leaves a lot of they again, when I say lesser developed nations, I mean that is the majority that's 150 nations on the on the on the on a rough calculation. And they're not they don't feel involved. They don't feel they're taken seriously in terms of support for the investment. 00;11;48;24 - 00;12;13;12 And I think they're looking looking at the developed world and they're saying, well, okay, you benefited from carbonized development then and now we're supposed to do on carbonized development and how is that going to work for us? And there's no answer to that. So I think it's extremely complex. And as you say, trying to build consensus around this is extremely difficult because any move forward does require political consensus as very, very hard to get these days. 00;12;13;12 - 00;12;30;16 I mean, you can you can look at Ukraine, you can look at you can look at the Sahel, you can look at many parts of the world where consensus are at a political level. It's very difficult, if not impossible. And then you factor into that, well, how do you then adopt action plans? How do you adopt roadmaps? Again, extremely difficult. 00;12;30;16 - 00;12;54;14 So I in my view, the the SDGs have come a bit unstuck because of the inability of developed nations to provide the necessary wherewithal, including funding. And therefore, of course, the other side of that coin is the inability of of many, many nations to advance those objectives, to achieve the goals that have been set out to reach those targets. 00;12;54;14 - 00;13;32;09 And that simply is not happening. And on SDG eight in the High-Level Policy Forum in July of this year and the the process of reporting on SDH was abandoned for reasons which I think are quite obvious, and no one had anything to report. So I point to that specifically. And also I was with a number of African nation ambassadors for dinner in Brussels two weeks ago, and they pointed out that they've stopped wearing their SDG lapel pins, you see. 00;13;32;11 - 00;13;56;13 And there's two reasons for that. One is in protest at the slow progress towards the SDGs, and secondly, because of, as they see it, their exclusion from the decision making process associated with the SDGs, which, as you can imagine, has a, you know, an annual review mechanism and and and all that sort of stuff. They feel excluded from that. 00;13;56;13 - 00;14;27;04 And my own view is they are for the reasons I've I think I've mentioned or alluded to and this brings this this promotes exclusion and inequity. And again, to repeat this, this wasn't in fashion 50 years ago to the extent that it is today. Now, it is a very, very strong policy and political force. And the institutions, the multilateral institutions that take leadership on these issues now have to find ways to to address that and to build inclusion in a very, very significant and meaningful way. 00;14;27;04 - 00;14;50;08 It's not just the family photo opportunities. It's making sure that these communities, that the stakeholders feel they're involved and they are involved. They're seeing the benefits. And I suppose to that extent, it's it's you know, it's politics as usual. Boy, those those challenges are just huge. It's it's quite an undertaking to to pursue those. But I guess that's what also makes it exciting as well. 00;14;50;10 - 00;15;11;10 Since this show is called Research and Action, we do talk a lot about the need to knock down barriers and support research, but research has several stages from basic all the way through clinical. What is especially important about supporting basic research and getting that right? What are those benefits? I suppose so. Simply put, you know, that's where it all starts. 00;15;11;10 - 00;15;45;05 And when we talk about basic research, we talk about basic research, but I would also call it pre competitive research. So that's a start for, you know, is everybody's friends and everybody is collaborating before they before they apply for a patent or before they discover discover something they can monetize or exploit or innovation in whichever way. And I think a very important aspect of this is the fact that it's by and large government funded, and this gives it a very important dimension, not to mention is seeding the potential for innovation. 00;15;45;07 - 00;16;08;28 And I often reflect that if you if you the government plays a huge role in science and technology. And now I don't have the details in front of me, but, you know, as far as I understand it, about a Tesla Enterprise wouldn't be where it is today without a small business loan from the US government. And of course, Mr. Gates was a beneficiary of government contracts at a very early stage in the development of Microsoft. 00;16;08;28 - 00;16;30;01 So just to point there to the importance of government funding across the board with respect to the government investment in science and technology in the pre competitive space, there's a clear recognition that without a synchrotron or without the government investing in synchrotron or large scale science facilities, then I think we're not going to have stakeholders who can build those. 00;16;30;03 - 00;16;52;12 So it simply simply won't happen. Many, many outcomes I think are evident in terms of the investment and in science and technology. You know, basically we have an advance in knowledge. Basic research seeks to understand the fundamental principles underlying various phenomena. And I think the curiosity driven research around this then leads to much innovation. But of course you don't know that at the beginning. 00;16;52;12 - 00;17;10;28 So I think there has to be a very strong political commitment to Blue skies research. And again, I stress the word political committee because it is a policy decision for a government, any government to invest in pretty competitive research, in science, capacity building, which is predominantly pre competitive and on in there in basic science. So I think that's that's hugely important. 00;17;10;28 - 00;17;34;11 Just to point to the policy dimension, I think that then leads to various innovations and that that that is applying. So you see a very clear narrative between basic research, innovation and applied research. Many groundbreaking innovations and technological advancements have emerged from the discoveries made in basic research. And I think this needs to be spelt out very often when a policymaker gets up in the morning. 00;17;34;18 - 00;17;56;18 That can be a complicated narrative. You know what I want to be getting from this? Why spend vast sums of money on basic research, blah, blah, blah? But I think when you look at the evidence, I think then the case is is compelling. But of course, that needs to be understood continuously, primarily by policymakers. And it does bring long term benefits, The outcomes of basic research might not lead to immediate benefits or applications. 00;17;56;18 - 00;18;25;27 However, these insights often lay the groundwork for future breakthroughs, which could and very often do have significant societal, economic or technological impacts over time. Problem solving is another reason to fund and do basic research educational value. Basic research plays a critical role in educating the next generation or generations, indeed, of scientists, researchers and thinkers. It provides a training ground for students to learn research methodologies, critical thinking and analytical skills. 00;18;26;00 - 00;18;52;06 And these values have multiple applications, multiple applications. And then we have cross-disciplinary insights. I think this is self evident. Basic research often leads to unexpected connections between different fields of study. These interdisciplinary insights can spark collaborations and innovations that otherwise wouldn't come to the fore. Intellectual curiosity, I think, needs also to be highlighted. Then we have the benefits coming from scientific advancement. 00;18;52;10 - 00;19;26;18 So I think Mike, there are many, many, many benefits in that. And I'd just like to point to really one example of basic research. You may not be a follower of radio astronomy or you might be about South Africa won a global competition to build the square kilometer Array telescope, the SKA, and that was a global competition in 2011 against the UK, against Chile, China, Brazil and Canada. 00;19;26;18 - 00;19;50;25 I believe there may be one or two other countries there as South Africa won the right to host and to build the UK and it is now doing that. It's probably a 30 year project. But here you have an example of of an African nation competing to build a hugely complex scientific instrument in the middle of the Karoo desert. 00;19;50;25 - 00;20;30;21 Now why do that? Many reasons to do it. But one of the compelling reasons that I learned from exposure to the project is the enormous commitment that the South African government and now, of course, to have partner countries, including Australia, that huge commitment they have made to education and training the next generation through the scale. And you will see in the system you'll see that many US multinationals, the Dell Corporation, IBM, Microsoft have very strong project association and collaboration with the UK and South Africa. 00;20;30;24 - 00;21;00;04 When the Economist wrote about the UK in 2016, I believe it was, they said this is the world's largest science project. And I think, you know, just it's worth reflecting on that. And this has enormous, enormous future potential. It has existing benefits to the scientific community and of course it is a huge flagship idea that provides a lightning rod for scientific collaboration across Africa and across the world. 00;21;00;11 - 00;21;26;13 At a very practical level, it brings many scientists to visit the facility to work with African and South African collaborators. So this is an ongoing benefit. I think a wonderful example of what our research infrastructure is, what basic science is, and why it should be funded. Yeah, what you just described is an enormous success story. But, you know, candidly, my optimism is challenged because so much of this does rely on government participation. 00;21;26;19 - 00;21;54;08 Yet it feels like as long as money and politics is in the picture, those are the anchors that can weigh things down. And against that backdrop is the science summit. So how did the science summit become a reality and was there any resistance to it or did anybody think this wasn't a good idea or not worth doing? The as far as I've learned, I mean, the response has been universally very, very positive, extremely positive. 00;21;54;11 - 00;22;26;03 And that's because the science summit is designed aimed to advance a greater awareness of the contribution of science to the SDGs. Now, how do you do that? You do that by bringing folk together. And those folk are not just the scientists. I mean, we're not organizing an ecology conference, we're not organizing a radio astronomy conference, we're organizing a science engagement process with U.N. leadership. 00;22;26;06 - 00;22;54;09 And more than that, we are showing how science needs to be inclusive. So to that end, we have a very strong narrative around inclusion. We have a very strong narrative around development, finance for scientific education, for science, performance and investment in science. And through doing that, we are education policymakers. We are engaging with policy makers. And I need to stress this invariably is it is a process. 00;22;54;16 - 00;23;15;28 But at the end of the day, policymakers that I have engaged with at many levels in Africa, Europe and the United States, they want to make the world a better place. I don't think there's any any doubt about that at very often in that quest, they are very remote from the outputs of science for the evidence that is there that shows that science delivers. 00;23;15;28 - 00;23;38;28 Of course, it's in the system. But very often the political system of political decision making is very human. It's a very natural process. It's not always empirical. And I think as you know, and possibly in in the Western world, we see that policy making is becoming more political with a small P. So it's into that environment that we are going and showing how science makes a difference. 00;23;39;05 - 00;24;08;26 Practically. We're showing how science delivers on the SDGs, we're showing how science delivers on the future challenges. And with reference to a very important aspect, we're also highlighting the the importance of enabling access to data now, and this is you'll probably be familiar with the European Union's General Data Protection Regulation, and there are other regulatory regimes in in the United States and Canada, Japan and Brazil and and elsewhere. 00;24;08;28 - 00;24;33;19 And now we are looking at the evolution of regulation concerning artificial intelligence. Now, these regulatory processes as one outcome have impacts on access to data and the use of data for scientific purposes. There is no global regulator, there's no global policymaker. How do we address a global coordination on these issues? And that's something we want to raise within the context of Science Summit to ensure that science is data enabled. 00;24;33;21 - 00;25;00;25 When we talk about science capacity building, essentially we are talking about improving the flow of data, access to data, use of data from machine learning and AI and other purposes, and extending that capability globally. And when that can happen, then you will see dramatically improved outcomes in terms of health research at the environment, biodiversity, energy and many, many other areas. 00;25;00;29 - 00;25;44;06 But we're not there yet. That very much is in the future. So we're trying to align the debate around the objective of creating these new innovations with the need for aligning energy policy, energy technology and other information technology around alignment on regulations. That's huge, huge importance. So we see that. We see the opportunity after the United Nations General Assembly to talk to governments, to talk to political leaders, to talk to Balsillie was to talk to diplomats, to talk to regulators, to talk to bureaucrats and show them what this is, how this matters, and very importantly, how they can include optimized policies to support science in future policies at the bloc level, at nation level. 00;25;44;06 - 00;26;13;20 And we have many, many meetings bringing forward scientists to show what they do, what's necessary in terms of government regulation and support to enable. So we're talking about creating the enabling policy and regular Tory environment for more and better science. And funnily enough, we don't say that's more that's about more money. We don't feel that. We don't think that what there is, is more opportunity and a great need for alignment at government and policy level. 00;26;13;23 - 00;26;39;06 And if every country in the world goes it alone in terms of creating regulation and creating policies, then we're looking at extreme fragmentation. There is much, much untapped potential for governments to work together, and that's one reason we're very happy to be working with Oracle, because, you know, from there, you know, as a company and, you know, forgive me if this is too simplistic, but they, they they create these machines that can communicate data. 00;26;39;06 - 00;27;07;29 And this is a this is a vital and vital a vital need globally. And how they do that and future, I think, will point to many, many future opportunities, which is a very important consideration, because with the science summit and at the level of the U.N., there's there's a huge recognition of the need to work with industry players and the importance of working with industry to deliver innovations, because it's not going to be a university center in it. 00;27;07;29 - 00;27;33;27 With the greatest respect to Cork University in Ireland, they're not going to be making the mess that's going to come through a company. So and industry. So this collaboration opportunity between academia, between governments and industry, I think is ripe for transformation, I think has enormous potential to address global challenges. So can you give us kind of a feel for what kind of speakers and sessions can be expected at the summit? 00;27;34;04 - 00;28;02;24 Yes, Michael, we've got a very inclusive approach to the summit, so we're covering a lot of things, but I suppose I would accept that we have a bias towards health on the health research. On the 13th of September, we have an all day plenary on on One Health, which is a perspective that brings together planet people and animal health into a, if you like, a one world view. 00;28;02;27 - 00;28;26;10 We have a lot of amazing speakers from the five continents who will be coming to that meeting. And what we want to do then is this is relatively rare. It's a relatively new area. By that I mean it's a relatively new or a policymaking. So where want to advance policymaking in this area? We want to also promote interdisciplinary research and show how research matters across these three areas because they cannot be addressed in isolation. 00;28;26;12 - 00;28;56;06 And we'd argue at the moment, by and large, that they are. If you look at national funding systems and national priorities and all the rest of it, they look at animal health or they look at human health or they look at biodiversity. But looking at all three I think is vital. That's our that's our flagship session on Wednesday the 13th on the 14th, Thursday the 14th, we're going to focus on on pandemic preparedness and we're going to bring together the leadership from the National Research Foundation in South Africa, from the African Union Commission, from the European Union. 00;28;56;06 - 00;29;33;16 Delighted to have Irene North steps. The director for the People Directorate in Brussels is coming to join us. For three days. We have Professor Cortes at Lucca from the Medical University of Graz, who leads many European Union research initiatives. But he was the main instigator of the European Union's biobanking research infrastructure, of biobanking, of molecular resources. We should infrastructure, which does pretty much as it says on the can, and we're looking to create a UN version of that, if you like, And look at how this capacity for biobanking is going to contribute. 00;29;33;16 - 00;29;57;01 So and pandemic burden, it's very, very important that we also have President Biden's science adviser, Dr. Francis Collins, former director of the and I and the in the United States, Then we will also have representatives from Dr. Sao Victor. So from the U.S. Academy for Medicine, National Academy for Medicine. He'll be presenting the US approach to pandemic preparedness, which is called 100 days Mission. 00;29;57;06 - 00;30;22;17 What you Need to Do in the first hundred Days. We're very excited about that and very, very much looking forward to using that as a template for a global approach. And while there's been a lot of focus on global strategies, which we obviously very much support, we want to take that global strategy approach to the level of action in terms of what capacity is needed, where's that capacity needed, How can the capacity be delivered? 00;30;22;19 - 00;31;09;02 So very much looking forward to pandemic preparedness as a highlight of the summit. Then on Friday, Friday the 15th of September would have a one day plenary on genomics capacity building with a focus on Africa. But the approach will be global, But bring it forward. Will How does the capacity work for pandemic? Sorry for genomics and has been led by global industry in terms of Illumina and it's been led again by data experts, and that really looks at a future for genomics capacity building in Africa, without which we are going to be or Africa is going to be extremely hampered in the development of medicine and related therapies. 00;31;09;04 - 00;31;37;12 So there are three of the sessions. We also have the Obama Foundation having a meeting on the on the 17th of September. We're going to bring philanthropic organizations together, are for lunch on the 15th. We are going to have a number of sessions around the Amazon with the Brazilian Fapesp, the Rio National Research Agency, and they'll be looking at the future of Amazon from the perspective of collaborative research and development and science. 00;31;37;15 - 00;32;06;00 We will be working with a number of legal experts with the law firm Ropes and Gray, who will bring together experts to identify scenarios for an enabling regulatory environment for genomics that's going to take place on the afternoon of the 16th. We are going to have a number of focus days. The government of of government of Ethiopia will be joining us and they'll be presenting how the Ethiopian government presents or approaches the SDGs. 00;32;06;00 - 00;32;27;18 From the point of view of enabling science. We have a similar approach from the government of Ghana. We will have the nice people from Mongolia, the government of Mongolia. They will be presenting a regional approach from the roof of the world, and we would have the same from Nepal, from India, from Japan, from Brazil and many other nations. 00;32;27;23 - 00;32;58;22 And that national approach is very, very important because again, we want to highlight the need for synergies, highlight the similarity between national approaches and then how they can be brought together and benefit from one another. We will also have a presentation from the editor of Nature, Magdalena Skipper at They'll be presenting a what they call a storytelling evening, and that's that's designed to inform and show how science careers evolve. 00;32;58;28 - 00;33;27;05 So so the community can get an understanding of of how that has worked in a number of individuals so very much at look at looking forward to that. I think that personal aspect is is very, very important. And we will be having a number of sessions with with investors how they are approaching investing in science and technology, how that investment can be better aligned between governments, industry, not for profits, philanthropy. 00;33;27;05 - 00;33;50;18 And we're feeling we're seeing that a lot of these organizations have similar objectives. So there's enormous potential to see how they can be more aligned, work together for common objectives and thereby increase possible benefits and outputs. So very much look forward to dose those discussions. In terms of our principal outputs, what we want to do really is three levels. 00;33;50;18 - 00;34;12;01 First is we want to increase participation and collaboration. So we want to bring people together. And one of the main outputs of the science summit last year, researchers discovered each other. They went away and they started collaborating. That wouldn't have happened if they hadn't met at the science. So that's one level. Second level is what our agenda is. 00;34;12;04 - 00;34;44;27 So the United Nations will convene the summit of the future in 2024. So the question we're asking everybody is what should the science agenda for that meeting look like? And we want to compile it. And with the 400 odd sessions we're running, we want to work with them and see how can they contribute to that, What priorities can they put forward and how do they look in terms of a specific objective which the United Nations can support in terms of energy attainment or the post SDG agenda? 00;34;44;29 - 00;35;22;06 And the third element we want to advance is better policy making, make better policies. We will have tennis knocked and Dennis is the chair of the Inter-Parliamentary Union Science Committee. The Inter-Parliamentary Union is a global organization and represents 138 parliaments around the world. This dialog is hugely, hugely important. So we're going to be working with Denis to see how his members so those legislators in those 140 odd countries can incorporate better global ideas into policymaking at a local level. 00;35;22;06 - 00;35;52;29 And I'm talking about I'm talking about Nepal, I'm talking about Ghana, I'm talking about Kenya, I'm talking about many, many countries. And then what we what we hope that that will achieve is real sustained change. And as we move towards the end of this decade, that's going to be hugely, hugely demanding. But I think if we build this global momentum and we drive this cooperation and instill a sense of cooperation among scientists globally, and also we say that, you know, scientists in fact, are policy policymakers. 00;35;52;29 - 00;36;10;12 I don't see this divide between policymakers and scientists. I think scientists have a huge amount to contribute to policymaking. So, in fact, they're the policymakers. They know a lot about health, They know a lot about what policies are needed to deliver better health. And we want to give them a voice. Well, as I mentioned, Oracle will be speaking and participating at the summit. 00;36;10;12 - 00;36;37;01 And you touched on it a little bit. But when you think about the role for industry players, especially technology giants like Oracle and what's needed to pursue the SDGs, we've talked on the show a good bit about the concept of open science and increasing access to scientific data. It feels like big advances in global health can't happen if those developing or lower middle income countries are kept at arm's length from data. 00;36;37;04 - 00;37;00;02 Absolutely, Mike. Absolutely. Very, very well said. And as I've outlined, is that one of the main impediments potentially to this is regulation by advanced nations, which impacts on less developed nations. So I think an industry has a huge role to play in that because, you know, industry and providing the wherewithal to to advance this data exchange. So we very much look to industry leadership. 00;37;00;02 - 00;37;16;20 And I think Oracle is going to be very instrumental there in showing and leading the way in terms of how data is enabled and how data systems can allow access to data use of data, and of course the use of data for machine learning. And I think that's something we need to learn a lot about, particularly in developing nations. 00;37;16;23 - 00;37;35;25 I also think that the United Nations Global Sustainability Report, the latest version of which is available in draft, and I think the final version will be published at the end of this month. Points to a huge role for for industry. My own view is that I think industry need to be much more at the table at this U.N. table. 00;37;35;25 - 00;37;56;24 I'm delighted to see that Oracle is joining us in this quest, because I think we need to build a narrative and I think it'll be for industry are going to be a very credible partner in terms of telling governments what is necessary, what's needed in terms of creating the space for data to do what data needs. And again, in particular in the countries that are going to be challenged in their quest for access to data. 00;37;56;27 - 00;38;33;03 And that presumes that they have the capacity to have the infrastructure. Many don't, but they're going to need to have that and the industry going to be critical in delivering that. And I think that's that's terribly, terribly clear. So that role for industry in delivering, I think, spans the optimization of policy, the optimization of regulation, the deployment of technology, the maintenance and sustainability of that technology, and of course for the advancement of that technology into different areas in its application, particularly in ICT application, in the areas health and energy and the environment, biodiversity, climate and so forth. 00;38;33;06 - 00;38;55;25 And I think this is something that provides a gives me a lot of optimism in future. And I think also almost we're looking at a, if you like, a post, arguably a post regulatory model where where technology will allow us to define the the remit of Data Act access. I don't think we're there yet, but I think this is this is possibly in future. 00;38;55;27 - 00;39;16;01 And again, Oracle and the colleagues from Oracle will be engaging in a number of discussions on the regulatory side, on the technical side, on the access to data side that's going to help the communities understand not necessarily the solution, but at least define the questions. I think define the questions. Then we have a much greater opportunity in obtaining the answers. 00;39;16;03 - 00;39;39;17 Well, also in my intro, I mentioned that you are founder and managing director of ISC Intelligence and Science. Tell us about that endeavor. What does that do? Well, that that mainly is devoted towards building body types, capacity and advising governments on science. Capacity Building that many faces is based around scientific infrastructures. And of course they come in in many, many flavors. 00;39;39;22 - 00;39;59;29 But ours really is around the design of research infrastructures that that tends to be quite a long, competitive, drawn out, complicated process. Of course, for any funding, there is a there is a competitive process. This takes a a number a number of years, very often for an award, then a subsequent number of years for a design phase to be completed. 00;40;00;05 - 00;40;21;02 Before then you move into construction and operation. Our primary focus is on the design phase and we've done that in in Africa. We do it in India, in in North America, Latin America. And one of our main reasons for focusing on this area is because it means the capacity is there to to allow science to do what it does. 00;40;21;02 - 00;40;46;01 I've mentioned the case of the SKA and in Africa there are many others. But I would say hitherto there's been a lot of differentiation between science capacity. And of course this is this is quite understandable. But I think increasingly in future that capacity will be effectively one big data machine. It won't matter what flavor of science you're doing, you're going to be dipping into a common data reserves. 00;40;46;01 - 00;41;23;05 Now, there's some caveats around that, such as a a synchrotron, for example, or a light source. I think these are, as you can imagine, specific unique instruments. But we're looking forward very much to have the director of the Office of Science in the United States, Dr. Esmond Barrett, talk to us about how this can work on a global level and what are the challenges and how the US experience in building these science infrastructures and capacities can then help many, many other countries to to advance towards not net, not necessary do the same, but at least be on a path to access such capacity. 00;41;23;05 - 00;41;52;08 So ESI has been very, very involved in that and also involved in the regulatory aspects of the impact of updated regulation on science is something we're very exercised about. If we feel that the scientific community historically, by which I mean maybe over the last 15 years have been very slow to understand the implications of regulation of science, but equally the regulatory bodies at national level, equally have been very slow to understand the impacts of science because their primary concerns are not science. 00;41;52;13 - 00;42;23;27 The primary concerns are as they see them is the protection of individual data, etc., etc., etc. and that's very worthy and noble. But then once you pull the thread, you see that that has aspects and implications for scientific endeavor. So we're working in that interface, ensuring or trying to ensure or trying to increase respective awareness and visibility. And now this is has a very sharp focus in the advent of a EIA, the Artificial Intelligence Act in the European Union, which will be defining for reasons we mentioned earlier. 00;42;23;27 - 00;42;43;12 Also, we are very active in that space and we're very particularly active and, and how this seen, how this impacts on less developed nations. Well, Declan, again, we appreciate you being on the show today. If people wanted to learn more about the science Summit or ISC intelligence and science, how can they do that? Main ways. The website for the Science Summit is Science Summit. 00;42;43;15 - 00;45;13;24 It is sciencesummitunga.com the company website is ISC intelligence dot com and then you'll find the usual links to Twitter and all the rest there. Very good. We've got it. And if you listen are are interested in how Oracle can simplify and accelerate your own scientific research. Just take a look at Oracle dot com slash research and see what you think and of course join us again next time for research and action.
Lincoln went to Cordis to find out why Dillon Cantrell hadn't delivered Lincoln's gold to Bingles, only to learn Dillon had been mugged by some thugs shaking down Cantrell & Cantrell. Lincoln is unhappy with said thugs and is paying them a visit. Meanwhile, Billy needs to learn how to fight and fast if he's going to survive the next few days. Can Magda teach him the basics? Written and performed by Scott Sigler Production Assistance by Allie Press Copyright 2023 by Empty Set Entertainment Theme music is the song “They're Watching Me” by SUPERWEAPON. Learn more about your ad choices. Visit megaphone.fm/adchoices
This week in Sunnydale, the competition is heating up faster than a vampire in sunlight! Cordis' complete lack of filter inspires a freshly dumped Buffy to awaken her inner homecoming queen and “stake” her claim at the crown. The dynamics of the Scooby gang get further splintered when Willow and Xander share a kiss that has all of us freaking out. They overcorrect by going #teamCordi and supporting her cut-throat campaign for the crown, leaving Buffy bewildered and kinda pissed!But that's not the only competition in Sunnydale this week! Mr. Trick has assembled a ragtag group of assassins to take part in Slayerfest '98 to collect the bounty on Buffy and Faith's heads! We've got Texture and Josie, supermodels, survivalists and Kulack who has the best damn mohawk we've ever seen! Of course, being that it's Sunnydale where all chaos ensues, Cordelia gets tangled into the mess of Slayerfest, so she and Buffy are forced to work together to try to get to homecoming in time to collect their crown. Can Buffy and Cordi put their fight on pause to escape from Mr. Trick's Slayerfest? Are Willow and Xander going to talk about THAT kiss? How does Ash feel now that we are FINALLY meeting THE MAYOR?! Tune in to find out!And don't forget to follow us on Instagram at the_rewatcher for special content! Tell us your #funfacts and join the conversation with other Rewatchers!New episodes come out every Monday or you can listen early on Amazon Music or early and ad-free by subscribing to Wondery Plus in Apple Podcasts or the Wondery App.Please support us by supporting our sponsors.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
When Buffalo Bills safety Damar Hamlin collapsed, seemingly lifeless, on Monday Night Football in January: the world stood still. But somewhere on Long Island, New York, one mother watched everything unfold knowingly, fully aware of what had happened to Hamlin. Because the cause of Hamlin's collapse was the same condition – Commotio Cordis – that had taken her son's life 23 years earlier. So today, Tisha Thompson shares the story of a decades-long mission that grew from that loss, which has saved hundreds of lives, including Damar Hamlin. Learn more about your ad choices. Visit megaphone.fm/adchoices
¿Qué es el “commotio cordis” o paro cardíaco por un golpe en el pecho?
¿Qué es el “commotio cordis” o paro cardíaco por un golpe en el pecho?
Commentary by Dr. Jonathan Piccini
A listener's email sparks an episode about this heart injury. We want to hear from you! Send us your stories to scissorsnscrubs@gmail.com and we may just read it on an upcoming episode.
Cardiac arrest that often takes place when an athlete sustains a sudden and sharp blow to the chest goes by a fancy Latin name. Hugh Calkins, a cardiologist and electrophysiologist at Johns Hopkins, explains. Calkins: Commotio cordis is a condition … What is commotio cordis? Elizabeth Tracey reports Read More »
Welcome to PICU Doc On Call, A Podcast Dedicated to Current and Aspiring Intensivists.I'm Pradip Kamat coming to you from Children's Healthcare of Atlanta/Emory University School of Medicine and I'm Rahul Damania, from Cleveland Clinic Children's Hospital. We are two Pediatric ICU physicians passionate about all things MED-ED in the PICU. PICU Doc on Call focuses on interesting PICU cases & management in the acute care pediatric setting so let's get into our episode:Welcome to our Episode about a 14-year-old male who collapsed on the baseball field.Here's the case presented by Rahul:A 14-year-old male athlete was playing in a high school baseball tournament when he was hit in the chest with a pitched ball. The impact caused him to collapse on the field. Bystander CPR was begun given his unresponsiveness and emergency medical services were immediately called. The patient was transported to the hospital. Upon arrival, he was unresponsive and had no pulse. An electrocardiogram (ECG) showed ventricular fibrillation, and advanced cardiac life support was initiated. After several shocks and cardiac compressions, the patient regained a pulse and was transferred to the pediatric intensive care unit for further evaluation and management.To summarize key elements from this case, this patient has:Been struck by a high-velocity object in the chestSuffered a cardiac arrest, likely due to an arrhythmia from the blunt chest traumaThe presentation brings up a concern for Commotio Cordis, our topic of discussion today!We wanted to create this educational episode in light of the recent medical event experienced by the Buffalo Bill's safety Damar Hamlin. His blunt chest trauma, which led to cardiac arrest, has been postulated to be due to commotio cordis. At the date of this record, we are glad that Damar Hamlin is on the road to recovery.Absolutely, let's dive in more into this topic, Let's start with a short multiple-choice question:The 14-year-old described in our case suffered cardiac arrest after blunt chest trauma. Based on the working diagnosis of comottio cordis, what is the most likely EKG finding which may be seen in this patient?A. Ventricular fibrillationB. Ventricular tachycardiaC. Complete heart blockD. AsystoleThe correct answer is A. In a study published in JAMA (2002; 287(9):1142-1146) which used data from the US Commotio Cordis registry maintained by the Minneapolis Heart Institute Foundation, reported that the most common arrhythmia out of the 128 confirmed cases, 82 of which had EKGs which could be analyzed was ventricular fibrillation. Three patients had Vtach, 3 had Bradyarrhythmia and 1 had complete heart block. Although 40 patients had asystole, this was unlikely to be the initial rhythm after impact. Interestingly, the majority of these rhythms were recorded at the scene.Rahul, What is the definition of Commotio...
Don't miss Cordis CEO Shar Matin talking about building a new company from a storied brand, M&A, and what to expect from Cordis now that it is privately owned and solely focused on medtech.
Just Jared and Mike for this episode but will have a surprise guest for the next episode. Get your questions in now! CLICK HERE to submit your question Be sure to check out the blog for more information on this episode. CLICK HERE for the blog 1) Ever since the Damar Hamlin incident I have had a lot of people ask about commotio cordis. I was wondering if you could provide a simple explanation of this? 2) I see a lot of other prehospital providers posting what seems to be opposition to the Bills/Bengals game being stopped when they are expected to just keep going after tough calls. Some similar posts also call out the huge pay discrepancies between the players and the medical support staff. What are your thoughts? CLICK HERE to watch us on YouTube
Today we are talking about Damar Hamlin, commotio cordis and cardiac arrest, how it is relevant to baseball, and what if anything can be done to help prevent it.We recently witnessed the clip of Buffalo Bills safety Damar Hamlin collapsing after a collision with Bengals wide receiver in a NFL football game. People have speculated that Hamlin went into cardiac arrest from commotio cordis. Our understanding is that for commotio cordis to occur, the impact has to occur in the right place (right over the heart), at the right time in the heart's rhythm, by an object of a specific size. In this case, an opponent's shoulder. The treatment is immediately administering CPR, and using an AED (automated external defibrillator) until medical professionals arrive.The National Operating Committee on Standards for Athletic Equipment (NOCSAE)is an independent, non-profit organization that funded research to develop the world's first performance standard to protect against commotio cordis in 2018. The performance standard applies to the protectors worn in the sports of baseball and lacrosse. Today, the National Federation of State High School Associations (NFHS) and NCAA require all catchers to wear protectors that meet the standard. Some of these products can include a traditional style chest protector but may also include compression shirts and coverings that are more suited for positional players or pitchers. For a complete list of current products that meet the standard, visit Safety Equipment Institute, which is the only entity that certifies equipment to NOCSAE standards.Disclaimer: we are not medical professionals so please consider that anything shared in this episode is NOT medical advice. We are just moms wanting to keep our kids as safe as possible while playing the sport they love, and doing some google research for you.Follow Moms and Baseball:Keep up with Moms and Baseball on our website: https://momsandbaseball.comFollow us on Facebook, Instagram, and TwitterJoin our Facebook group, Parents and BaseballYou can also listen to episodes on Moms and Baseball Facebook pageArticles used for this episode:https://www.washingtonpost.com/sports/2023/01/05/commotio-cordis-mitigating-risks/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445066/https://www.sportsmedtoday.com/commotio-cordis-va-88.htmhttps://www.chicagotribune.com/investigations/ct-chest-protectors-commotio-cordis-standard-met-20160408-story.htmlhttps://nocsae.orghttps://www.seinet.org/search.htmsection=SportsAthleticsandRecreation#sections=NOCSAE_collapse3,NOCSAE_Baseball_collapse31
2023 CME Conferences and Board Reviews Elemental Medicine-PANRE Board Review Course-Live Webinar VIRTUAL CLASSROOM Feb 21 , 2023 @ 08:00 AM - Feb 24 , 2023 @ 05:00 PM Urgent Care Conference Orlando ,FLORIDA Mar 13 , 2023 @ 07:00 AM - Mar 16 , 2023 @ 12:30 PM Demystifying Emergency Medicine Conference KEY WEST ,FLORIDA Jun 05 , 2023 @ 07:00 AM - Jun 08 , 2023 @ 12:30 PM Urgent Care Conference LAS VEGAS ,NEVADA Oct 16 , 2023 @ 07:00 AM - Oct 19 , 2023 @ 12:30 PM
Another million-to-one shot event has taken place and of course nobody can ask whether or not the vaccine contributed to it. It's the latest in the long list of Covid related topics we're not supposed to talk about and we certainly can't question. Article discussed: https://www.lewrockwell.com/2023/01/joseph-mercola/covid-boosters-trigger-metastasis/ Support the Show: https://www.peddlingfictionpodcast.com/support-the-show/
Contributor: Jared Scott, MD Educational Pearls: Commotio cordis is sudden ventricular fibrillation precipitated by direct impact to the chest A national registry, US Commotio Cordis Registry, reports an average of 10-20 cases annually 95% of reported cases occur in males, indicating possible genetic component Average age of patient in registry is 15 Most cases occur during sporting events (baseball in particular), in addition to physical altercations and industrial accidents Treatment is high quality CPR and early defibrillation Survival rate is improving but remains around 35% In recent events, American football player Damar Hamlin survived a Commotio cordis event after being tackled on field and receiving CPR References Link MS. Commotio cordis: ventricular fibrillation triggered by chest impact-induced abnormalities in repolarization. Circ Arrhythm Electrophysiol. 2012;5(2):425-432. doi:10.1161/CIRCEP.111.962712 Maron BJ, Poliac LC, Kaplan JA, Mueller FO. Blunt impact to the chest leading to sudden death from cardiac arrest during sports activities. N Engl J Med. 1995;333(6):337-342. doi:10.1056/NEJM199508103330602 Summarized by Kirsten Hughes, MS4 | Edited by John Spartz, MD, & Erik Verzemnieks, MD The Emergency Medical Minute is excited to announce that we are now offering AMA PRA Category 1 credits™ via online course modules. To access these and for more information, visit our website at https://emergencymedicalminute.org/cme-courses/ and create an account.
In this episode we discuss Commotio Cordis and Damar Hamlin. We have Emergency Room physician Dr. Travis Smith on to break it down for us.
If you hadn't heard of commotio cordis prior to this past week, you likely have now. On January 2, 2023, Damar Hamlin of the […]
If you hadn't heard of commotio cordis prior to this past week, you likely have now. On January 2, 2023, Damar Hamlin of the […]
We are all praying for Buffalo Bills' safety, Damar Hamlin, after he was hit, causing a cardiac event, sending him to the ICU. This is a nightmare for any athlete, and disheartening for family, friends and fans.As nurses, medical students, even parents, when viewing these types of tragic events, it is natural to think about what you would do in an emergency situation like this. Especially a parent attending a child's sporting event, having the knowledge and ability to help out in an emergency can start to feel more important than ever.On today's episode, rapid response nurse and our host, Sarah Lorenzini, has invited guest Dr. Jeremy Alland, the official physician for the Chicago Bulls basketball team, to help us unravel what happened to Damar Hamlin on the football field, and how we can better prepare ourselves for cardiac events as medical professionals in non-medical settings.We go over sports medicine doctor's roles, common cardiac events that occur in sporting events, how to treat them, and how to stay vigilant (not paranoid) in situations where there is a possibility of a cardiac event.This episode isn't only for medical professionals or students, this is also for anyone who wants to be prepared and helpful in emergency situations.Tune in today to hear practical information and advice that could potentially help save someone's life. Topics discussed in this episode:Dr. Alland's role as the Chicago Bulls team physicianWhat happened to Damar Hamlin?What is commotio cordis?Explanation of the how sports related cardiac events occur for non-nursesA possibility of what happened to Damar HamlinWhat happens when a player collapses on the field? What is an emergency action plan in sports medicine?Why AEDs are important in an emergencyHow was Damar Hamlin able to stand up and collapse again after he was hit?Advice for lay people and medical professionals witnessing a sports emergencyA free app to download to locate AEDs in your area: Pulse Point AEDhttps://apps.apple.com/app/id867150971Who is the best person to do CPR in an emergency?To connect with Dr. Jeremy Alland, head to his instagram page @JeremyAllandMD or check out his podcast by visiting www.yourdoctorfriendspodcast.com!
Commotio cordis is caused by the blunt impact of a hard object directly over the heart occurring during a specific window of ventricular repolarization leading to immediate collapse, ventricular fibrillation, and cardiac arrest. This episode focuses on risk factors and management of this rare but catastrophic injury. PEMBlog @PEMTweets on Twitter My Mastodon account @bradsobo […]
![Being [at Work]](https://ivyfm.s3.amazonaws.com/i320/636094.jpg)
How much more might you achieve if you started looking at everything with an opportunity instead of a limitation lens? Selen Turner, the Global Talent and Organizational Development Director at Cordis, experienced a pivotal moment when she stopped saying, “I'm not being given what I need,” and started focusing on all the resources she had available. From there, Selen realized she and her team had the power inside of themselves to reach their goals. In this episode, Selen shares her journey, starting with her first full-time job on a cruise ship, all the way to leading large enterprise projects, and how the former influences the latter. Listen in to learn how to fulfill your vision by taking ownership and breaking through any limiting thoughts. Quick Links: Connect with Selen: https://www.linkedin.com/in/selenturner/ Learn more about Cordis: https://cordis.com/na/home Connect with Andrea: https://www.linkedin.com/in/leaderdevelopmentcoach Learn more about HRD: https://hrdleadership.com/
Prayers out to Damar Hamlin, his family and friends. Quick explanation of commotio cordis, defending Skip Bayless.
Congratulations, folks, you made it through another trip around the sun. Your prize for achieving this accomplishment? Another heaping dose of crazy in case your supply was running low. Sara Gonzales, BlazeTV host and Ron DeSantis fanatic, was in attendance at Ron DeSantis' inauguration in Florida. She fills us in on the festivities in the Sunshine State. The newly reelected governor of Florida appeared rather presidential, but does that mean he's running in 2024? We know Donald Trump is putting his name back in the race, but is it too late? Has Trump's moment passed him by? Damar Hamlin, a player for the Buffalo Bills, tragically collapsed on the field Monday, leading many to speculate what caused this otherwise healthy athlete's heart to suddenly stop. While everyone's praying for Hamlin to pull through, it's important that we're allowed to ask questions about what caused this horrifying incident. The powers that be would have you believe his heart stopping was the result of a hit to the chest, medically known as commotio cordis. Remember, he who controls the vocabulary ultimately controls the narrative. Today's Sponsors: Sign up today to save FIFTY PERCENT on your first subscription year! There's never been a better time to go to http://StartMail.com/CHAD and join the thousands of people who have chosen StartMail for their email security needs! If you're ready to take action, join thousands of guys who have saved their hair with Keeps. Visit http://KEEPS.com/LOSS for 50 percent off your first order. Keep American farming going by signing up at http://MoinkBox.com/CHAD RIGHT NOW and listeners of this show get FREE filet mignon in every order for a year. That's one year the best filet mignon you'll ever taste, but for a limited time. Learn more about your ad choices. Visit megaphone.fm/adchoices
One of the scariest scenes unfolded this past Monday night for the world to see. There was great excitement for this game, as two of the best teams in the NFL were competing head-to-head with playoff implications. A packed stadium and a buzz that only great teams can generate. Shortly after the game had started the unthinkable occurred… 24-year-old Damar Hamlin was injured on the field. Just a routine tackle. A play that you've seen numerous times in a game and one that you would never think twice about. As Hamlin stood up, he soon then collapsed back down and lay motionless on the field. Doctors rushed by his side, administered CPR, and 20 minutes later he was rushed to the hospital by ambulance. Dr. Grant Garcia wanted to share some information about what happened and explain what Commotio Cordis is: a trauma to your chest, a type of injury that is usually associated with Baseball, Lacrosse, Hockey, and combat sports. Dr. Garcia wants to let coaches and families know how to be prepared and recognize the difference between a common injury and a life-threatening one. --- Support this podcast: https://anchor.fm/nyseasportstalk/support
Dr. Bryan Smith, cardiologist at the University of Chicago Medical Center, joins Lisa Dent to discuss what might have caused Buffalo Bills safety Damar Hamlin to suffer cardiac arrest after a tackle on the field. Dr. Smith also explain what commotio cordis is and whether that may be what Hamlin experienced. Follow The Lisa Dent […]
Dr. Ramchandani Discusses the Buffalo Bills - Damar Hamlin Injury and Commatio Cordis. What is Commatio Cordis? Why does it happen? Please donate to Damar Hamlin's GoFundMe - https://www.gofundme.com/f/mxksc-the-chasing-ms-foundation-community-toy-driveMayo Clinic Website: Commatio Cordis: https://www.mayoclinic.org/diseases-conditions/sudden-cardiac-arrest/symptoms-causes/syc-20350634
Contributor: Travis Barlock, MD Educational Pearls: Gauge and length of catheter are determinants of flow rate Smaller gauges produce higher flow rate Longer catheters reduce flow rate Common IV gauges produce predictable rates of flow: 20 gauge = 60 cc/min 18 gauge = 105 cc/min 16 gauge = 220 cc/min Central lines typically have two 18 gauge and one 16 gauge lumen, both with long catheters, producing the following slower flow rates: 18 gauge = 26 cc /min 16 gauge = 55 cc/min Sheath Introducers, such as Cordis brand catheters, are wider and shorter than classic central lines. Flow rates are 150 cc/min, or 130 cc/min with pressure bag Maximal flow allows for one unit of blood to be delivered over one minute It is important to consider length and gauge of catheter when patients require fluids References Greene N, Bhananker S, Ramaiah R. Vascular access, fluid resuscitation, and blood transfusion in pediatric trauma. International Journal of Critical Illness and Injury Science. 2012;2(3):135. doi:10.4103/2229-5151.100890 Khoyratty SI, Gajendragadkar PR, Polisetty K, Ward S, Skinner T, Gajendragadkar PR. Flow rates through intravenous access devices: an in vitro study. J Clin Anesth. 2016;31:101-105. doi:10.1016/j.jclinane.2016.01.048 Summarized by Kirsten Hughes, MS4 | Edited by John Spartz, MD, & Erik Verzemnieks, MD In an effort to promote diversity, equity, and inclusion in Emergency Medicine, The Emergency Medical Minute is proud to present our 2nd annual Diversity and Inclusion Award. We support increasing the representation of underrepresented groups in medicine and extend this award to individuals applying to emergency medicine residencies during the 2022-2023 cycle. For information on award eligibility and the application process, visit https://emergencymedicalminute.com/edi-award/ Donate to EMM today!
On today's show, we have a very special treat in the form of the Trail & Ultra Running Husband and Wife team of Abby and Cordis Hall. Abby has been lighting up the ultra scene with multiple finishes over the years at races like the North Face Endurance Challenge, Leadville Trail 100, and of course Ultra Trail du Mont-Blanc or UTMB - most recently with an impressive 3rd place podium finish. Cordis is no stranger to the ultra scene with impressive finishes at UTMB, TDS and most recently a 100K finish at Innsbruck Alpine Trailrun Festival. We get into their origins as runners and husband and wife by biting off massive challenges together - sometimes failing, sometimes succeeding, but always loving and supporting one another. I recorded this way back in February and the episode sat on the shelf since then, but with the relaunch, I wanted to share the conversation with all of you. So, if you're ready for the show, crank it up and let's go! Abby & Cordis Web Site https://www.abbyandcordis.com/ Abby Hall on Instagram https://instagram.com/abby.k.hall Cordis Hall on Instagram https://instagram.com/cordisimo Faster Forward on Instagram https://instagram.com/fasterforwardshow Troy Busot (troy@busot.com) https://instagram.com/troybusot
Investing in Tech Startups is not like investing in Med Tech or Bio Med or Life Sciences. Listen to hear the best practices for investing in innovation that can change the way we live and thrive. Karen Rands interviews Tico Blumenthal, Life Science Angels, to share with her Compassionate Capitalist Podcast audience the journey from innovation corporate exec to innovation investor. Tico demonstrates how he is a Compassionate Capitalist as he shares his passion, putting his investment capital to work with the intent of serving the aim of better health, globally. To that end he advises and invests in a diverse portfolio of early stage ventures, including implantable diagnostics, cardiovascular devices and digital health. Listen to learn about Tico's passion about innovation and some best practices for assessing deals ripe for investment. Tico Blumenthal, formerly, the head of Global Strategic Marketing at Cardinal Health's Cordis interventional vascular division, and is currently the VP of Product at Eko still working in the cardiopulmonary field. He is a Board Member and Chair of the Medical Device Screening Committee of Life Science Angels, who make Seed/Series A investments across life sciences, digital health and med devices. Tico's personal portfolio includes genetic diagnostics, oncology-focused biotech therapeutics, structural heart, interventional oncology tools, digital health, infectious disease diagnostics, and adjacencies. To learn more about Life Science Angels, visit https://www.lifescienceangels.com/ To learn more about how Karen is working to bring a fresh new generation of investors to the market as compassionate capitalists, and to understand how she helps investors screen and evaluate opportunities, visit http://kugarand.com The interview is also available on youtube: https://youtu.be/sVJWnjddVAw
© 2020-2025 Ivy Podcast Discovery LLC
